Description

4-[2-(Trifluoromethoxy)Phenyl]-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine is a high-value, heterocyclic organic compound featuring a fused imidazopyridine core, which is of significant interest in advanced pharmaceutical research and development. This molecule's unique structure, incorporating a trifluoromethoxy phenyl substituent, makes it a critical pharmacophore and key synthetic intermediate for creating novel bioactive molecules. It is primarily utilized by pharmaceutical companies, contract research organizations (CROs), and academic research laboratories engaged in drug discovery programs targeting central nervous system (CNS) disorders, inflammation, and other therapeutic areas.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of novel drug candidates, particularly for CNS-targeted therapies.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in early-stage drug discovery.
• Biochemical Tool Compound: Employed in vitro and in vivo to study specific biological pathways and protein interactions.
• Active Pharmaceutical Ingredient (API) Development: Acts as a precursor in the multi-step synthesis of potential active pharmaceutical ingredients.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis and scale-up projects.
• Academic Research: Utilized in university and institutional labs for pioneering research in organic synthesis and pharmacology.

Basic Information

Product Name	4-[2-(Trifluoromethoxy)Phenyl]-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine
CAS No.	1010878-91-7
Molecular Formula	C13H12F3N3O
Molecular Weight	283.25 g/mol
Synonyms	4,5,6,7-Tetrahydro-4-[2-(trifluoromethoxy)phenyl]-3H-imidazo[4,5-c]pyridine; 3H-Imidazo[4,5-c]pyridine, 4,5,6,7-tetrahydro-4-[2-(trifluoromethoxy)phenyl]-; 4-(2-Trifluoromethoxyphenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine; 1010878-91-7; 4-[2-(Trifluoromethoxy)phenyl]-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 4-(2-(Trifluoromethoxy)phenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with each shipment, documenting critical quality attributes. Our facilities and processes are designed to meet the stringent requirements of cGMP (current Good Manufacturing Practice) for pharmaceutical intermediates, ensuring reliability for your research and development pipelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). For long-term storage, consider storing under an inert atmosphere to maintain stability. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (MS)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.